E-LIB Suche - Ergebnisse für: Willett, C G

1

Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvan..:

Karukonda, P. ; Czito, B. ; Duffy, E....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. S12 , 2023

Link: https://doi.org/10.1016/..

2

Prospective Evaluation of Interim FDG-PET Imaging during Ch..:

Leng, J.X. ; Niedzwiecki, D. ; Hong, J.C....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e563-e564 , 2022

Link: https://doi.org/10.1016/..

3

The Role of Hypofractionated Radiation Therapy in the Manag..:

Stephens, S.J. ; Oyekunle, T. ; Niedzwiecki, D....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e78-e79 , 2021

Link: https://doi.org/10.1016/..

4

Toxicity and Dosimetric Parameters of Ablative Radiation Th..:

Sperduto, W. ; Oyekunle, T. ; Niedzwiecki, D....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e78 , 2021

Link: https://doi.org/10.1016/..

5

Fluence Map Prediction for Fast Pancreas Stereotactic Body ..:

Wang, W. ; Sheng, Y. ; Palta, M....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. S128-S129 , 2020

Link: https://doi.org/10.1016/..

6

Association of Interim FDG-PET During Chemoradiation for An..:

Kent, C.L. ; Hong, J.C. ; Rushing, C.N....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e584 , 2020

Link: https://doi.org/10.1016/..

7

Simulating Planners' Interactions With the Treatment Planni..:

Zhang, J. ; Wang, C. ; Sheng, Y....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e255-e256 , 2020

Link: https://doi.org/10.1016/..

8

Differences in Clinicopathologic Features and Response to N..:

Corrigan, K.L. ; Jacobs, C.D. ; Williamson, H....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e623 , 2020

Link: https://doi.org/10.1016/..

9

Imaging & Biomarker Correlates on Outcomes in a Phase II Tr..:

Kent, C.L. ; Marin, D. ; Niedzwiecki, D....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E238-E239 , 2019

Link: https://doi.org/10.1016/..

10

Surgical and Pathologic Outcomes in Patients on a Phase II ..:

Stephens, S.J. ; Czito, B. ; Zhang, X....
International Journal of Radiation Oncology*Biology*Physics. 102 (2018) 3 - p. S180 , 2018

Link: https://doi.org/10.1016/..

11

Neoadjuvant Chemoradiation Therapy in Nonpancreatic Periamp..:

Abdelazim, Y.A. ; Palta, M. ; Willett, C.G....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E132 , 2017

Link: https://doi.org/10.1016/..

12

Intratreatment FDG-PET Imaging to Predict Radiation Induced..:

Tandberg, D.J. ; Cui, Y. ; Hong, J.C....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E189 , 2017

Link: https://doi.org/10.1016/..

13

The Impact of Biologically Equivalent Dose on Tumor Control..:

Stephens, S.J. ; Abdelazim, Y.A. ; Thomas, S.M....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E188-E189 , 2017

Link: https://doi.org/10.1016/..

14

The Role of Chemoradiation Therapy in Initially Metastatic ..:

Abdelazim, Y.A. ; Rushing, C.N. ; Palta, M....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E132-E133 , 2017

Link: https://doi.org/10.1016/..

15

The Use of Reirradiation in Locally Recurrent, Nonmetastati..:

Susko, M. ; Lee, J. ; Salama, J.K....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E192-E193 , 2016

Link: https://doi.org/10.1016/..